About us
Caduceus Technology Partners, LLC has a global network of highly trained and skilled: Physicians, scientists, engineers, attorneys, specialized researchers, business, accounting and commercialization executives; who work collectively as contractors to bring new medical innovations to the market, timely and cost efficiently as needed.
Our broad global perspective and network, industry experience, medical backgrounds and education, provides efficiency, connections and strategic global planning for cost efficient life science device innovation and medical device commercialization.
Renee White, MS, PA - Managing Partner - Global Management
Renee has held executive leadership roles for over 25 yrs in medicine, finance and business. She has expertise identifying disruptive medical device technologies and providing the strategic guidance to commercialize new innovations for commercialization.
Previously dual-careered licensed in both medicine and finance, she enjoys working closely with physician entrepreneurs, scientists, device engineers, and investors. She has founded several small companies including a Registered NASD firm, Emerald Street Market Advisors, LLC a Registered Investment Advisory portfolio management firm, which managed physician funds and trust accounts.
Renee has been a guest Judge and panel member at several international venture conference events and personally established a global network of commercialization executives for assisting with product development. As the founder of Caduceus Technology Partners, LLC her interest is in assisting physician entrepreneurs with product development and also partnering with foreign companies preparing to expand their medical technologies into the USA.
Renee graduated from Baylor College of Medicine as a Physician Assistant and practiced Internal Medicine for several years (including running clinical research trials), then returned for a Master's degree in Science and Technology Commercialization at The University Of Texas (IC2) McCombs School Of Business in Austin, TX. Her interests in medical device innovation began while working with the partial artificial heart research (LVAD) team with the Texas Heart Institute, and participating as the Heart Transplant Coordinator during the first implantation of the LVAD in a patient, proving a successful bridge for cardiac augmentation while a donor heart was located.
Her strengths include evaluating medical device innovation opportunities for product development, executive operations and management, strategic commercialization planning, detailed project management, technology assessments, physician collaboration and clinical research trials.
Diogo B. MBA - Strategic Partner Europe - EU Management
John Lin, MD, MBA - Strategic Partner China and Asia Medical Advisor
Dr. Lin has been involved in several start-up companies. He has helped to manage and oversee many successful joint ventures in China. He also conducted cancer research at M.D. Anderson Cancer Center, Baylor College of Medicine, and The University of Texas Health Science Center. He has extensive experience in working with R&D projects, Import & Export; and has also worked closely with manufacturing, marketing, sales and investor relations.
Dr. John Lin has served as the principal of Wellin Investment Inc since 1994. His current responsibilities include project development, technology transferring with licensing, strategy formulation, corporate fund-raising and alliance formation. Dr. Lin has served as a director with Life Science of Sun & Sun Capital Holding Pte. Ltd., Singapore.
Dr. Lin was also selected as the Chairman of the Board of the US-China Federal Association of Business Councils; a non-profit organization. Dr. Lin is fluent in English and Chinese with Taiwanese. He holds a MBA from the University of Houston and an MD, from Fudan University Medical School in China.
Regulatory Associates - FDA - CE Mark and other countries
Brad Turnley - Innovation Scout and Liaison
Brad assists Caduceus Technology as an Innovation Scout and Liaison with surgeons. Brad owns a surgical company in Houston representing companies as Richard Wolf, Smith & Nephew Versajet, and Lumitex MD.He spends much of his day inside operating rooms, assisting surgeons with the new products he represents.Brad graduated with a Business Management Degree from Stephen F. Austin University and has been a healthcare representative since 1999 with such companies as Medline and Arthrex.
Through Brad's talents, he has achieved many awards for business growth including;2009 49% Sales Growth for Richard Wolf;2008 "Rookie of the Year Award'' for Richard Wolf Medical Instruments, and 2002 Top 7 finalists out of 258 Wound Care Sales for Medline Industries.
Carmelo Otero MD - Cardiovasular Surgeon - Medical Advisor
Dr. Otero is a highly skilled cardiovascular surgeon with interests in new medical device innovations. He is a Medical Advisor to Caduceus Technology Partners and a Clinical Strategic Alliance Partner to provide key regulatory assistance for technologies seeking FDA approval.
Military trained, Dr. Otero performed his Residency and Cardiothoracic Surgical Fellowship at Brooke Army Medical Center in Texas. In 1990-91, Dr. Otero was Chief of Thoracic Surgery 46th Combat Support Hospital in Saudi Arabia during the 1st Gulf war, before moving to Fitzsimons Army Medical Center in Colorado as Chief of the Cardiothoracic Surgery Service.
Dr. Otero's interest in new technologies includes providing product evaluations and validation studies which has included his interest in off-pump coronary bypass technologies. He has assisted during development of off-pump products in addition to intra-operative fluorescent angiography technology. He has also assisted in all stages of the regulatory process including participation in acute and chronic animal labs, and pre-market studies for device companies such as Guidant and Baxter, as well as leading clinical trials as the Principal Investigator.
Dr. Otero enjoys working with medical innovations and has been a Surgical Preceptor for several companies including Boston Scientific and robotically assisted cardiac surgery.He is a practicing cardiovascular surgeon who embraces breaking edge new technologies to assist his patient's needs.
Terry E. White, CRNA
Chief Anesthetist
Taken too soon by pancreatic cancer at the age of 55 yrs,
Pancreatic Cancer is a disease poorly understood and horribly
underfunded because it is hard to diagnose until it is too late.
This disease is in need of funding for research, clinical trials,
and improved diagnostic innovations.
Please support the development of new diagnostics technologies,
and medical innovations, for your family and mine.
The challenges of illness, affects us all.
